日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CLCC1 promotes hepatic neutral lipid flux and nuclear pore complex assembly.

CLCC1促进肝脏中性脂质通量和核孔复合物组装。

Mathiowetz Alyssa J, Meymand Emily S, Parlakgül Güneş, van Hilten Niek, Torres Emily F, Artico Leonardo L, Deol Kirandeep K, Lange Mike, Pang Stephany P, Doubravsky Cody E, Roberts Melissa A, Jorgens Danielle M, Zalpuri Reena, Kang Misun, Boone Casadora, Parks Brian W, Zhang Yaohuan, Morgens David W, Newman Emily Tso, Zhou Yingjiang, Talukdar Saswata, Grabe Michael, Ku Gregory, Levine Tim P, Arruda Ana Paula, Olzmann James A

CLCC1 governs ER bilayer equilibration to maintain lipid homeostasis.

CLCC1 控制内质网双层膜平衡,以维持脂质稳态。

Wu Lingzhi, Wang Jianqin, Wang Yawei, Yang Junhan, Yao Yuanhang, Wang Yonglun, Huang Dong, Hu Yating, Xu Xinxuan, Wang Renqian, Du Wenjing, Shi Yiting, Li Quan, Liu Lu, Zhu Yuangang, Li Shijie, Chen Feng-Jung, Zhang Xiuqin, Wang Xiao, Guo Qiang, Xu Li, Li Peng, Chen Xiao-Wei

Molecular mechanism of exchange coupling in CLC chloride/proton antiporters

CLC氯/质子反向转运体中交换偶联的分子机制

Aydin, Deniz; Chien, Chih-Ta; Kreiter, Jürgen; Nava, Amy R; Portasikova, Jasmina M; Fojtik, Lukas; Sobecks, Briana L; Mosquera, Catalina; Man, Petr; Dror, Ron O; Chiu, Wah; Maduke, Merritt

Metabolic characterization of tumor-immune interactions by multiplexed immunofluorescence reveals spatial mechanisms of immunotherapy response in non-small cell lung carcinoma (NSCLC)

通过多重免疫荧光技术对肿瘤-免疫相互作用进行代谢表征,揭示了非小细胞肺癌(NSCLC)免疫治疗反应的空间机制

Monkman, James; Kilgallon, Aaron; Lawler, Clara; Tubelleza, Rafael; Aung, Thazin Nwe; Warrell, Jonathan H; Vathiotis, Ioannis; Trontzas, Ioannis P; Gavrielatou, Niki; Nyein Chan, Nay Nwe; Czertok, Rotem; Bookstein, Shai; O'Byrne, Ken; Markovits, Ettai; Rimm, David L; Kulasinghe, Arutha

TRIM32 promotes anoikis resistance and metastasis in NSCLC by degrading CHEK2 to enhance IL-6 secretion.

TRIM32 通过降解 CHEK2 来增强 IL-6 的分泌,从而促进 NSCLC 的抗凋亡和转移。

Xu Jia, Liu Wenjun, Chen Li, Zhang Juan, Zhang Dongze, Huang Xue, Zhang Guangbo

Tumor microbiome-transcriptome crosstalk identifies Prevotella as an immunotherapeutic predictor in NSCLC.

肿瘤微生物组-转录组相互作用表明普雷沃氏菌是NSCLC免疫治疗的预测因子。

Wang Na, Ma Lifang, Huang Yugang, Zhou Xionghui, Rong Yuan, Long Fei, Qiu Wanbo, Wu Si, Hu Yue, He Xin, He Jiurong, Tian Sufang, Hu Weidong, Yuan Chunhui, Wang Fubing

A genome-wide genetic screen reveals the P2Y2-integrin axis as a stabilizer of EGFR mutants in non-small cell lung cancer (NSCLC).

全基因组遗传筛选揭示 P2Y2-整合素轴是非小细胞肺癌 (NSCLC) 中 EGFR 突变体的稳定剂。

Du Yafei, Wang Wenjing, Goh Hui Chin, Vaiyapuri Thamil Selvan, Raju Anandhkumar, Hsiao Yu-Chun, Wang Cheng Chun, Agrawal Vanisha, Mohideen Noorul Farzana, Mohd Mazian Norhidayah Binte, Karatekin Feride, Wang Wendy Kehan, Lakshmanan Manikandan, Gupta Komal, Chang Han, Le Guezennec Xavier, Bard Frederic, Tan Daniel S W, Tergaonkar Vinay, Hung Mien-Chie, Liu Xiaogang, Hong Wanjin, Boopathy Gandhi T K

Phase I/II clinical trial of a melanoma vaccine targeting shared non-mutated antigens and a shared mutated BRAF neoantigen with an agonistic CD40 antibody (CDX-1140) plus TLR3 agonist (poly-ICLC)

针对共同的非突变抗原和共同的突变BRAF新抗原的黑色素瘤疫苗的I/II期临床试验,采用激动性CD40抗体(CDX-1140)和TLR3激动剂(poly-ICLC)

Ninmer, Emily K; Petroni, Gina R; Gastman, Brian R; Gaughan, Elizabeth M; Isaacs, James M; Haden, Kathleen; Kaur, Varinder; Wages, Nolan A; Chianese-Bullock, Kimberly A; Smith, Kelly T; Wright, Paul; Bryant, Jennifer; Dunlap-Brown, Marya; Engel, Jack A; Bekiranov, Stefan; Mauldin, Ileana S; Truong, Thach-Giao; Bullock, Timothy N J; Slingluff, Craig L Jr

Integrative multiomic profiling of cfDNA methylation and EV-miRNAs identifies immunotherapy-outcome molecular subtypes in NSCLC.

cfDNA甲基化和EV-miRNA的整合多组学分析可识别NSCLC中的免疫治疗结果分子亚型。

Onieva Juan Luis, Pérez-Ruiz Elisabeth, Figueroa-Ortiz Laura Cristina, Jurado José Miguel, Martínez Beatriz, Carlos Benítez José, Rueda-Domínguez Antonio, Barragán Isabel

Dual PD-1/IL-2Rα targeting restores CD8(+) T cell fitness via STAT5/CD47 axis in SMARCA4-deficient NSCLC.

双重 PD-1/IL-2Rα 靶向治疗通过 STAT5/CD47 轴恢复 SMARCA4 缺陷型 NSCLC 中的 CD8(+) T 细胞功能。